Hao Tian

1.3k total citations · 1 hit paper
45 papers, 936 citations indexed

About

Hao Tian is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hao Tian has authored 45 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hao Tian's work include Prostate Cancer Treatment and Research (9 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (6 papers). Hao Tian is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (6 papers). Hao Tian collaborates with scholars based in China, United States and Taiwan. Hao Tian's co-authors include Meng Qian, Qiang Zhao, Jingli Hou, Yongzhe Che, Qi Liu, Yuanjie Niu, Yating Zhang, Adam C. Midgley, Yangping Liu and Xin Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and ACS Nano.

In The Last Decade

Hao Tian

43 papers receiving 928 citations

Hit Papers

An Injectable Dual‐Function Hydrogel Protects Against Myo... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Tian China 17 499 233 129 123 115 45 936
Yong Hwa Jo South Korea 15 437 0.9× 231 1.0× 123 1.0× 97 0.8× 118 1.0× 25 957
Hitomi Fujisaki Japan 19 476 1.0× 146 0.6× 158 1.2× 55 0.4× 117 1.0× 60 1.0k
Silvia Baldari Italy 18 603 1.2× 273 1.2× 103 0.8× 110 0.9× 183 1.6× 24 1.2k
Shiou Zhu China 11 669 1.3× 236 1.0× 223 1.7× 74 0.6× 66 0.6× 13 1.1k
Rutulkumar Patel United States 11 520 1.0× 279 1.2× 157 1.2× 147 1.2× 120 1.0× 21 1.1k
Ya Gao China 20 491 1.0× 200 0.9× 86 0.7× 96 0.8× 127 1.1× 75 1.1k
Witold N. Nowak Poland 17 551 1.1× 142 0.6× 79 0.6× 81 0.7× 202 1.8× 34 1.0k
Xiaohong Lü China 23 640 1.3× 231 1.0× 116 0.9× 104 0.8× 67 0.6× 48 1.2k
Liquan Wu China 15 430 0.9× 156 0.7× 71 0.6× 110 0.9× 126 1.1× 27 984

Countries citing papers authored by Hao Tian

Since Specialization
Citations

This map shows the geographic impact of Hao Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Tian more than expected).

Fields of papers citing papers by Hao Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Tian. The network helps show where Hao Tian may publish in the future.

Co-authorship network of co-authors of Hao Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Tian. A scholar is included among the top collaborators of Hao Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Tian. Hao Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xingkai, Dong Dai, Siqi Zhang, et al.. (2025). A Cyclic Peptide‐Based Radiotheranostic Agent for Urokinase‐Type Plasminogen Activator in Tumors. Chemistry - A European Journal. 31(28). e202500479–e202500479. 1 indexed citations
2.
Tian, Hao, Siqi Zhang, Hongyi Huang, et al.. (2025). 64 Cu-Labeled Stapled Peptide-Based Radiopharmaceuticals Targeting MDM2/MDMX for Pan-p53 Tumors. Journal of Medicinal Chemistry. 68(21). 23389–23405. 1 indexed citations
3.
Tian, Hao, J. R. Gao, Yichi Chen, et al.. (2025). Self-propelled ferroptosis nanoinducer for enhanced cancer therapy. International Journal of Extreme Manufacturing. 7(3). 35501–35501. 4 indexed citations
4.
Tian, Hao, et al.. (2024). Research on a Self-Coordinated Optimization Method for Distributed Energy Resources Targeting Risk Mitigation. Distributed Generation & Alternative Energy Journal. 659–690.
5.
Tian, Hao, Meng Qian, Haoyan Huang, et al.. (2023). Intracellular delivery of nitric oxide enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction. Science Advances. 9(48). eadi9967–eadi9967. 12 indexed citations
6.
Tian, Hao, et al.. (2023). Robotic Grasping of Pillow Spring Based on M-G-YOLOv5s Object Detection Algorithm and Image-Based Visual Serving. Journal of Intelligent & Robotic Systems. 109(3). 2 indexed citations
7.
Zhu, Shimiao, Yang Zhao, Zheng Zhang, et al.. (2023). HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell Death and Disease. 14(3). 215–215. 6 indexed citations
8.
Cui, Miao, Svetlana Bezprozvannaya, Hao Tian, et al.. (2023). Transcription factor NFYa controls cardiomyocyte metabolism and proliferation during mouse fetal heart development. Developmental Cell. 58(24). 2867–2880.e7. 11 indexed citations
9.
Hou, Shuai, et al.. (2023). MS2-MBP-Based Affinity Purification of Nucleus- or Cytoplasm-Localized lncRNA–Protein Complexes Formed In Vivo. Methods in molecular biology. 2666. 231–245. 1 indexed citations
10.
Liang, Xiaoli, Hao Tian, Wenye Liu, et al.. (2023). Seed color in lettuce is determined by the LsTT2, LsCHS, and Ls2OGD genes from the flavonoid biosynthesis pathway. Theoretical and Applied Genetics. 136(12). 241–241. 3 indexed citations
11.
Chen, Xuanrong, Yi Shao, Shimiao Zhu, et al.. (2022). Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer. Cell Death and Disease. 13(11). 927–927. 5 indexed citations
12.
Chou, Fu-Ju, Yuhchyau Chen, Hao Tian, et al.. (2020). Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity. Cancer Letters. 495. 100–111. 27 indexed citations
13.
Zhu, Shimiao, Hao Tian, Xiaodan Niu, et al.. (2019). Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer. Oncogene. 38(24). 4875–4884. 32 indexed citations
14.
Tian, Hao, et al.. (2019). MicroRNA-363-3p/p21(Cip1/Waf1) axis is regulated by HIF-2α in mediating stemness of melanoma cells. Neoplasma. 66(3). 427–436. 19 indexed citations
15.
Hu, Jieping, Jing Tian, Shimiao Zhu, et al.. (2017). Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression. British Journal of Cancer. 118(1). 88–97. 61 indexed citations
16.
Jin, Yue, Bo Huo, Xueqi Fu, et al.. (2017). LSD1 knockdown reveals novel histone lysine methylation in human breast cancer MCF-7 cells. Biomedicine & Pharmacotherapy. 92. 896–904. 8 indexed citations
17.
Hou, Shuai, Na Li, Qian Zhang, et al.. (2016). XAB2 functions in mitotic cell cycle progression via transcriptional regulation of CENPE. Cell Death and Disease. 7(10). e2409–e2409. 30 indexed citations
18.
Li, Hui, Shuai Hou, Hao Tian, et al.. (2015). HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/−KTS isoforms. RNA Biology. 12(12). 1364–1371. 1 indexed citations
19.
Yu, Hongliang, Li Yin, Xuesong Jiang, et al.. (2014). Effect of Metformin on Cancer Risk and Treatment Outcome of Prostate Cancer: A Meta-Analysis of Epidemiological Observational Studies. PLoS ONE. 9(12). e116327–e116327. 61 indexed citations
20.
Tian, Hao, et al.. (2013). [Impacts of bleeding and cupping therapy on serum P substance in patients of postherpetic neuralgia].. PubMed. 33(8). 678–81. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026